アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/27 | 1,913 | 1,927 | 1,913 | 1,923 | +17 | +0.9% | 3,973,100 |
2023/02/24 | 1,912 | 1,914 | 1,893 | 1,906 | +15.5 | +0.8% | 6,264,000 |
2023/02/22 | 1,903.5 | 1,905.5 | 1,883.5 | 1,890.5 | -14 | -0.7% | 6,959,800 |
2023/02/21 | 1,890.5 | 1,914 | 1,887 | 1,904.5 | +18.5 | +1% | 5,532,100 |
2023/02/20 | 1,897 | 1,904 | 1,880.5 | 1,886 | -41 | -2.1% | 10,785,000 |
2023/02/17 | 1,915.5 | 1,933.5 | 1,914.5 | 1,927 | -6 | -0.3% | 4,360,700 |
2023/02/16 | 1,922 | 1,939.5 | 1,921.5 | 1,933 | +1.5 | +0.1% | 4,512,200 |
2023/02/15 | 1,930.5 | 1,937 | 1,925.5 | 1,931.5 | +1.5 | +0.1% | 4,016,600 |
2023/02/14 | 1,925 | 1,934 | 1,920 | 1,930 | +14.5 | +0.8% | 3,798,500 |
2023/02/13 | 1,915 | 1,930.5 | 1,905 | 1,915.5 | +0.5 | ±0% | 4,870,300 |
2023/02/10 | 1,917 | 1,926 | 1,909 | 1,915 | -8.5 | -0.4% | 7,706,100 |
2023/02/09 | 1,919 | 1,931.5 | 1,919 | 1,923.5 | -9 | -0.5% | 6,100,900 |
2023/02/08 | 1,929.5 | 1,943.5 | 1,921.5 | 1,932.5 | +18.5 | +1% | 6,181,200 |
2023/02/07 | 1,932.5 | 1,960.5 | 1,911.5 | 1,914 | +12.5 | +0.7% | 9,338,800 |
2023/02/06 | 1,910 | 1,911.5 | 1,897 | 1,901.5 | +12 | +0.6% | 4,306,700 |
2023/02/03 | 1,899.5 | 1,909 | 1,888 | 1,889.5 | -10.5 | -0.6% | 4,204,000 |
2023/02/02 | 1,874.5 | 1,904.5 | 1,874 | 1,900 | -2 | -0.1% | 6,000,000 |
2023/02/01 | 1,918.5 | 1,923 | 1,899 | 1,902 | -10.5 | -0.5% | 4,218,100 |
2023/01/31 | 1,925.5 | 1,935 | 1,912 | 1,912.5 | -1 | -0.1% | 4,739,100 |
2023/01/30 | 1,919 | 1,929.5 | 1,910.5 | 1,913.5 | -25 | -1.3% | 4,889,800 |
2023/01/27 | 1,954 | 1,957.5 | 1,930 | 1,938.5 | -36.5 | -1.8% | 4,857,400 |
2023/01/26 | 2,002 | 2,009 | 1,969.5 | 1,975 | -2.5 | -0.1% | 5,045,000 |
2023/01/25 | 1,971 | 1,989.5 | 1,969 | 1,977.5 | +9.5 | +0.5% | 4,901,000 |
2023/01/24 | 1,970.5 | 1,977.5 | 1,946 | 1,968 | +15.5 | +0.8% | 4,321,300 |
2023/01/23 | 1,973.5 | 1,975 | 1,951.5 | 1,952.5 | -6 | -0.3% | 3,995,500 |
2023/01/20 | 1,943 | 1,958.5 | 1,928 | 1,958.5 | +18.5 | +1% | 4,290,300 |
2023/01/19 | 1,939.5 | 1,946 | 1,927.5 | 1,940 | -20 | -1% | 4,644,300 |
2023/01/18 | 1,909.5 | 1,968.5 | 1,898.5 | 1,960 | +66.5 | +3.5% | 5,799,800 |
2023/01/17 | 1,921 | 1,927 | 1,893.5 | 1,893.5 | -10 | -0.5% | 4,211,500 |
2023/01/16 | 1,890 | 1,917 | 1,885 | 1,903.5 | +16.5 | +0.9% | 5,030,000 |
2023/01/13 | 1,892 | 1,906 | 1,877 | 1,887 | -34.5 | -1.8% | 5,828,200 |
2023/01/12 | 1,913.5 | 1,936.5 | 1,906 | 1,921.5 | +7 | +0.4% | 3,111,500 |
2023/01/11 | 1,903 | 1,919 | 1,896.5 | 1,914.5 | +13 | +0.7% | 4,429,300 |
2023/01/10 | 1,919 | 1,938 | 1,899 | 1,901.5 | -22.5 | -1.2% | 4,021,800 |
2023/01/06 | 1,917.5 | 1,929.5 | 1,913 | 1,924 | +10.5 | +0.5% | 3,584,500 |
2023/01/05 | 1,948.5 | 1,949.5 | 1,908.5 | 1,913.5 | -17.5 | -0.9% | 3,575,900 |
2023/01/04 | 1,990 | 1,993.5 | 1,926 | 1,931 | -75.5 | -3.8% | 4,782,100 |
2022/12/30 | 2,015 | 2,024.5 | 2,004.5 | 2,006.5 | -18.5 | -0.9% | 3,908,600 |
2022/12/29 | 2,016 | 2,026 | 2,003.5 | 2,025 | -8 | -0.4% | 2,900,400 |
2022/12/28 | 2,030 | 2,041 | 2,022.5 | 2,033 | +4 | +0.2% | 2,668,800 |
2022/12/27 | 2,042 | 2,049 | 2,023.5 | 2,029 | -6.5 | -0.3% | 2,252,700 |
2022/12/26 | 2,041 | 2,049 | 2,035.5 | 2,035.5 | +1.5 | +0.1% | 1,208,100 |
2022/12/23 | 2,048.5 | 2,057.5 | 2,026.5 | 2,034 | -17.5 | -0.9% | 3,196,200 |
2022/12/22 | 2,060 | 2,061.5 | 2,037 | 2,051.5 | +3 | +0.1% | 3,988,900 |
2022/12/21 | 2,068 | 2,072.5 | 2,040.5 | 2,048.5 | -23 | -1.1% | 4,760,700 |
2022/12/20 | 2,109.5 | 2,113 | 2,009 | 2,071.5 | -34.5 | -1.6% | 5,154,700 |
2022/12/19 | 2,135 | 2,136 | 2,099 | 2,106 | -42.5 | -2% | 3,938,400 |
2022/12/16 | 2,145.5 | 2,152.5 | 2,133 | 2,148.5 | -17.5 | -0.8% | 4,492,200 |
2022/12/15 | 2,170.5 | 2,188.5 | 2,163 | 2,166 | -20 | -0.9% | 2,809,900 |
2022/12/14 | 2,181.5 | 2,194.5 | 2,172.5 | 2,186 | +17 | +0.8% | 3,893,300 |
301~
350
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,100円 | +2.9% | +72.2% | 4.90% | 90.32倍 | 1.70倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 416,500円 | +2.0% | +4.2% | 4.71% | 112.66倍 | 0.90倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 650,500円 | +6.0% | +131.3% | 1.84% | 14.13倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 714,400円 | +4.6% | +0.9% | 2.38% | 12.42倍 | 1.64倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 665,500円 | +1.7% | -2.9% | 2.40% | 44.42倍 | 2.18倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム